To shed further light on the role of physician attire in the medical setting, MPR interviewed Nathan Houchens, MD, Assistant Professor of Internal Medicine at the University of Michigan in Ann Arbor.
Researchers sought to identify disparities in risk to prevent, identify, and treat COVID-19-related severe illness and limit diverging outcomes for vulnerable subgroups.
The International Myasthenia Gravis/COVID-19 Working Group has published a short guidance statement on the management of MG and Lambert-Eaton myasthenic syndrome during this novel pandemic.
In patients with COVID-19, higher sputum cell expression of ACE2 and TMPRSS2 was observed in certain patients while lower expression was found in patients who used inhaled corticosteroids.
Publication of the revised clinical practice guidelines for Clostridioides difficile infection was followed by significant increases in use of oral vancomycin and fidaxomicin, and a significant decrease in use of oral metronidazole.
The North American Society Leadership drafted a consensus report synthesizing recommendations by cardiovascular societies dealing with the safe reinstatement of elective procedures and tests.
Haymarket Medical Network, a part of business media company Haymarket Media, Inc., is proud to join the Ad Council’s first ever Private Marketplace (PMP) along with other partners Cadreon, The Trade Desk and Acxiom.
While health experts continued to call for a national strategy to test more Americans for coronavirus, President Donald Trump on Monday announced a “blueprint” for boosting testing capacity as some states began reopening their economies.
The FDA has approved MenQuadfiTM Meningococcal (Groups A, C, Y, W; Sanofi Pasteur) Conjugate Vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y in patients aged ≥2 years.
The American Heart Association and the American Academy of Pediatrics have released interim guidance for resuscitation care for pediatric patients with known or suspected COVID-19.
Hear me, protect me, prepare me, support me and care for me was the message health care professionals dealing with the coronavirus disease 2019 (COVID-19) pandemic delivered to their organizations.
Although tenofovir alafenamide coformulated with emtricitabine has a marginally more benign side effect profile compared with tenofovir disoproxil fumarate coformulated with emtricitabine the additional cost of the newer HIV PrEP is not justifiable.
The FDA has issued a joint warning letter with the Federal Trade Commision (FTC) to the Genesis II Church of Health and Healing for selling chlorine dioxide products known as “Miracle Mineral Solution” that claim to treat or prevent COVID-19.
